Basal-cell carcinoma Treatment
Basal cell carcinoma (also known as basal cell carcinoma or basal cell cancer) is malignancy of the most common skin, and one of the most common cancers in the United States. Although basal cell carcinoma has a low metastatic potential, this tumor can cause significant destruction and disfigurement by invading surrounding tissues
Click here more health care news
In the United States, approximately 3 out of 10 Caucasians develop a basal cell carcinoma in her lifetime. This tumor accounts for about 70% of non-melanoma skin cancers. In 80 percent of all cases, the basal cell carcinoma affects the skin of the head and neck. It also seems that there is an increase in the incidence of basal cell cancer stem in recent years
basal cell carcinoma can be divided into three groups, based on growth patterns.
superficial basal cell carcinoma, formerly known basal cell carcinoma in situ, is characterized by proliferation of neoplastic surface basal cells. This tumor is usually sensitive to chemotherapy issue, such as Aldara (imiquimod), or fluorouracil.
infiltrative basal cell carcinoma, which also includes morfea and micronodular basal cell cancer is more difficult to treat with conservative methods, given its tendency to penetrate into the deeper layers of the skin.
